BioLight Life Sciences Ltd. (TLV:BOLT)
662.40
-17.20 (-0.93%)
Apr 1, 2025, 5:24 PM IDT
BioLight Life Sciences Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 9.72 | 5.28 | 13.39 | 33.47 | 29.99 | Upgrade
|
Short-Term Investments | - | 0.25 | 1.25 | 0.25 | 1.16 | Upgrade
|
Trading Asset Securities | 3.75 | 3.12 | 2.99 | - | 19.96 | Upgrade
|
Cash & Short-Term Investments | 13.47 | 8.64 | 17.63 | 33.71 | 51.11 | Upgrade
|
Cash Growth | 55.81% | -50.96% | -47.72% | -34.04% | 27.93% | Upgrade
|
Other Receivables | 0.88 | - | - | 0 | 0.09 | Upgrade
|
Receivables | 0.88 | - | - | 0 | 0.09 | Upgrade
|
Prepaid Expenses | - | 0.07 | 0.09 | 0.04 | 0.01 | Upgrade
|
Other Current Assets | - | 0.34 | 0.31 | 0.25 | 0.25 | Upgrade
|
Total Current Assets | 14.35 | 9.06 | 18.02 | 34 | 51.46 | Upgrade
|
Property, Plant & Equipment | 4.16 | 4.27 | 3.34 | 3.26 | 3.16 | Upgrade
|
Long-Term Investments | 13.53 | 19.37 | 34.88 | 25.82 | 10.06 | Upgrade
|
Goodwill | - | - | - | - | 0.15 | Upgrade
|
Other Intangible Assets | 0.69 | 0.69 | 0.69 | 0.15 | - | Upgrade
|
Other Long-Term Assets | 1.4 | 0.07 | 0.09 | 0.95 | - | Upgrade
|
Total Assets | 34.12 | 33.45 | 57.01 | 64.17 | 64.83 | Upgrade
|
Accounts Payable | 0.13 | 0.24 | 0.3 | 0.15 | 0.58 | Upgrade
|
Accrued Expenses | - | 1.51 | 1.71 | 1.62 | 1.52 | Upgrade
|
Current Portion of Leases | 0.53 | 0.09 | 0.53 | 0.44 | 0.46 | Upgrade
|
Current Unearned Revenue | - | 0.48 | - | - | - | Upgrade
|
Other Current Liabilities | 1.4 | - | - | - | - | Upgrade
|
Total Current Liabilities | 2.07 | 2.32 | 2.54 | 2.21 | 2.56 | Upgrade
|
Long-Term Leases | 0.07 | - | - | - | 0.47 | Upgrade
|
Long-Term Unearned Revenue | 1.25 | 0.84 | 0.78 | 0.54 | 0.56 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | - | 1.13 | Upgrade
|
Total Liabilities | 3.38 | 3.15 | 3.32 | 2.75 | 4.72 | Upgrade
|
Common Stock | 276.84 | 11.65 | 11.44 | 11.4 | 11.36 | Upgrade
|
Additional Paid-In Capital | - | 250.78 | 250.46 | 250.42 | 248.34 | Upgrade
|
Retained Earnings | -249.97 | -242.82 | -216.8 | -208.96 | -209.34 | Upgrade
|
Comprehensive Income & Other | - | 10.17 | 8.07 | 7.84 | 8.86 | Upgrade
|
Total Common Equity | 26.88 | 29.78 | 53.17 | 60.7 | 59.22 | Upgrade
|
Minority Interest | 3.86 | 0.53 | 0.52 | 0.72 | 0.89 | Upgrade
|
Shareholders' Equity | 30.74 | 30.3 | 53.69 | 61.42 | 60.11 | Upgrade
|
Total Liabilities & Equity | 34.12 | 33.45 | 57.01 | 64.17 | 64.83 | Upgrade
|
Total Debt | 0.6 | 0.09 | 0.53 | 0.44 | 0.93 | Upgrade
|
Net Cash (Debt) | 12.87 | 8.55 | 17.1 | 33.27 | 50.18 | Upgrade
|
Net Cash Growth | 50.47% | -49.98% | -48.61% | -33.70% | 27.04% | Upgrade
|
Net Cash Per Share | 2.76 | 1.84 | 3.74 | 7.25 | 11.05 | Upgrade
|
Filing Date Shares Outstanding | 4.66 | 4.66 | 4.64 | 4.56 | 4.54 | Upgrade
|
Total Common Shares Outstanding | 4.66 | 4.66 | 4.58 | 4.56 | 4.54 | Upgrade
|
Working Capital | 12.28 | 6.74 | 15.49 | 31.79 | 48.9 | Upgrade
|
Book Value Per Share | 5.77 | 6.39 | 11.62 | 13.31 | 13.04 | Upgrade
|
Tangible Book Value | 26.19 | 29.09 | 52.48 | 60.55 | 59.07 | Upgrade
|
Tangible Book Value Per Share | 5.62 | 6.25 | 11.47 | 13.28 | 13.00 | Upgrade
|
Machinery | - | 0.64 | 0.64 | 0.54 | 0.54 | Upgrade
|
Leasehold Improvements | - | 0.07 | 0.07 | 0.07 | 0.19 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.